Raptor Pharmaceutical Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
Raptor Pharmaceutical Corp had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $2.10 million as of 2015-12-31, per its 10-K filed 2016-02-26.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2016-02-26
- 2015-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $2.10M.
- 2014-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $26.60M.
- 2013-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $46.90M.
- 2013-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $7.85M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value as first filed |
|---|---|---|
| 2015-12-31 | $2.10M 10-K · filed 2016-02-26 | |
| 2014-12-31 | $26.60M 10-K · filed 2015-03-02 | |
| 2013-12-31 | $46.90M 10-K · filed 2014-03-17 | |
| 2013-03-31 | $7.85M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $6.80K 10-KT/A · filed 2014-05-12 | $6.92M 10-KT · filed 2013-03-14 |
| 2012-08-31 | $4.32M 10-K · filed 2012-11-14 | |
| 2012-02-29 | $1.60M 10-Q · filed 2013-05-08 | |
| 2011-08-31 | $3.30M 10-K · filed 2012-11-14 |